Caplin Point Laboratories subsidiary Caplin Steriles Ltd, an Indian sterile product manufacturing company that has been approved by both the US Food and Drug Administration and the EU authorities for good manufacturing practice, has entered into a distribution agreement with Xellia Pharmaceuticals for abbreviated new drug applications of five generic injectables in the US market.
Out of the five generic injectables that Caplin has licensed to Xellia, one has already received approval and will be...